Koers Alliqua Biomedical Inc Nasdaq
Aandelen
US0196212007
Biotechnologie & Medisch Onderzoek
Omzet 2017 | - | Omzet 2018 | - | Marktkapitalisatie | 5 4,63 |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -11 mln. -10,2 mln. | Nettowinst (verlies) 2018 | -5 mln. -4,63 mln. | EV/omzet 2017 * | - |
Nettoliquiditeiten 2017 * | - 0 | Nettoliquiditeiten 2018 * | - 0 | EV/omzet 2018 * | - |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 * |
-
| Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 * |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Julien Mamet
FOU | Founder | - | 01-10-07 |
Rick Orr
CEO | Chief Executive Officer | - | 01-12-10 |
Dina Gonzalez
DFI | Director of Finance/CFO | - | 01-01-10 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Eckard Weber
BRD | Director/Board Member | 73 | - |
Stanley Abel
BRD | Director/Board Member | - | 01-01-08 |
Dennis Podlesak
CHM | Chairman | 66 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,37% | 44,96 mld. | |
-1,01% | 42,65 mld. | |
+46,00% | 41,85 mld. | |
-5,31% | 29,04 mld. | |
+9,34% | 26,08 mld. | |
-21,69% | 19,03 mld. | |
+6,23% | 12,75 mld. | |
+26,99% | 12,06 mld. | |
-3,38% | 11,75 mld. |